Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized,…

By S. Cohen, E. Hurd, J. Cush, M. Schiff, Michael E. Weinblatt, L. Moreland, J. Kremer, M. Bear, W. Rich, D. McCabe. Arthritis & Rheumatism, 2002

646 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/864e46324389ada53186a3ba1b6b892b22cd884c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. I. McInnes

In Molecular Biology

1. Daniel Aletaha
2. J. Smolen
3. I. McInnes
4. T. Mak
5. T. Berger
6. David Mcilwain

In Rheumatology

1. Daniel Aletaha
2. J. Smolen
3. I. McInnes
4. S. Gaffen

Citations in the corpus

• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (2010, positive): “however, this RCT did not include a third arm using the combination of both so that it is not clear to date whether in patients with early RA monotherapy with tocilizumab is similarly or less effective than combination therapy with tocilizumab and MTX. Currently, the largest array of safety informat”
• Caspase functions in cell death and disease. (2013, background): “However, human trials of agents targeting IL-1 in rheumatoid arthritis (RA) (Drevlow et al. 1996; Bresnihan et al. 1998; Jiang et al. 2000; Cohen et al. 2002; Genovese et al. 2004; Alten et al. 2008), as well as in other rheumatic diseases such as SLE, psoriatic arthritis, and osteoarthritis…”